[Cancer Management and Research] A retrospective review of 30 patients who underwent resection of spinal tumor caused by metastatic SCLC demonstrated that surgery was critical to improving patients QOL and performance status.
[Cancer Management and Research] Researchers sought to quantify the effect of the measures taken to reduce transmission of the coronavirus on diagnosis and treatment of nasopharyngeal cancer.
[Cancer Management and Research] Researchers sought to determine if apatinib-related hypertension was a predictor of drug efficacy in patients with advanced HCC.
[Cancer Management and Research] This review discusses advances in minimal residual disease monitoring in patients with CML, including its role in defining treatment response, choosing the best therapeutic strategy, and selecting patients who may be eligible for TKI discontinuation.
[OncoTargets and Therapy] PLELC is a rare and distinct subtype of NSCLC associated with Epstein-Barr virus infection. Usually detected at early stage, prognosis is better for patients with PLELC than for those with other subtypes of NSCLC. This review discusses etiology, diagnosis, and treatment of the disease.
[Breast Cancer: Targets and Therapy] Nanosomal docetaxel lipid suspension was developed to minimize toxicity issues associated with conventional docetaxel. The efficacy and safety of NDLS-based chemotherapy in breast cancer was evaluated in this retrospective study.
[Cancer Management and Research] Researchers present a comparison study on the sensitivity and accuracy of 3 types of imaging studies — contrast-enhanced ultrasound, MRI, and computed tomography — in diagnosing and classifying pancreatic cystic neoplasms.
[Oncotargets and Therapy] Some data support use of immunotherapy for breast cancer; however, as a monotherapy, only a small percentage of patients will benefit from the treatment. This review discusses the current status of efforts to improve immunotherapy through combinations with other therapies.
[Cancer Management and Research] This review focuses on how identification of molecular alterations and risk stratification would contribute to individualized-therapeutic decision-making in AML.
[Journal of Hepatocellular Carcinoma] In this review, the authors discuss the use of imaging techniques and radiological biomarkers to monitor treatment response in patients with advanced HCC undergoing antiangiogenic therapy, a key to decisions on whether to continue treatment or initiate second-line therapy.